343 related articles for article (PubMed ID: 22172912)
1. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
2. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis.
Pardo Masferrer J; Murcia Mejía M; Vidal Fernández M; Alvarado Astudillo A; Hernández Armenteros ML; Macías Hernández V; Soto Pérez R; Mirada Ferre A
Clin Transl Oncol; 2010 Jan; 12(1):43-8. PubMed ID: 20080470
[TBL] [Abstract][Full Text] [Related]
3. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
4. Randomized, prospective assessment of moisturizer efficacy for the treatment of radiation dermatitis following radiotherapy after breast-conserving surgery.
Sekiguchi K; Ogita M; Akahane K; Haga C; Ito R; Arai S; Ishida Y; Tsukada Y; Kawamori J
Jpn J Clin Oncol; 2015 Dec; 45(12):1146-53. PubMed ID: 26491204
[TBL] [Abstract][Full Text] [Related]
5. Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy.
Zhao H; Zhu W; Jia L; Sun X; Chen G; Zhao X; Li X; Meng X; Kong L; Xing L; Yu J
Br J Radiol; 2016; 89(1058):20150665. PubMed ID: 26607642
[TBL] [Abstract][Full Text] [Related]
6. Prophylactically applied Hydrofilm polyurethane film dressings reduce radiation dermatitis in adjuvant radiation therapy of breast cancer patients.
Schmeel LC; Koch D; Stumpf S; Leitzen C; Simon B; Schüller H; Vornholt S; Schoroth F; Müdder T; Röhner F; Garbe S; Schmeel FC; Schild HH; Wilhelm-Buchstab TM
Acta Oncol; 2018 Jul; 57(7):908-915. PubMed ID: 29463159
[TBL] [Abstract][Full Text] [Related]
7. Topical betamethasone for prevention of radiation dermatitis.
Omidvari S; Saboori H; Mohammadianpanah M; Mosalaei A; Ahmadloo N; Mosleh-Shirazi MA; Jowkar F; Namaz S
Indian J Dermatol Venereol Leprol; 2007; 73(3):209. PubMed ID: 17561562
[TBL] [Abstract][Full Text] [Related]
8. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
9. A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation.
Ho AY; Olm-Shipman M; Zhang Z; Siu CT; Wilgucki M; Phung A; Arnold BB; Porinchak M; Lacouture M; McCormick B; Powell SN; Gelblum DY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):325-333. PubMed ID: 29726361
[TBL] [Abstract][Full Text] [Related]
10. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients.
Becker-Schiebe M; Mengs U; Schaefer M; Bulitta M; Hoffmann W
Strahlenther Onkol; 2011 Aug; 187(8):485-91. PubMed ID: 21786113
[TBL] [Abstract][Full Text] [Related]
11. Melatonin for Prevention of Breast Radiation Dermatitis: A Phase II, Prospective, Double-Blind Randomized Trial.
Ben-David MA; Elkayam R; Gelernter I; Pfeffer RM
Isr Med Assoc J; 2016; 18(3-4):188-92. PubMed ID: 27228641
[TBL] [Abstract][Full Text] [Related]
12. Phase II study assessing the effectiveness of Biafine cream as a prophylactic agent for radiation-induced acute skin toxicity to the breast in women undergoing radiotherapy with concomitant CMF chemotherapy.
Szumacher E; Wighton A; Franssen E; Chow E; Tsao M; Ackerman I; Andersson L; Kim J; Wojcicka A; Ung Y; Sixel K; Hayter C
Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):81-6. PubMed ID: 11516855
[TBL] [Abstract][Full Text] [Related]
13. Randomized, Prospective, Open-label Phase III Trial Comparing Mebo Ointment With Biafine Cream for the Management of Acute Dermatitis During Radiotherapy for Breast Cancer.
Geara FB; Eid T; Zouain N; Thebian R; Andraos T; Chehab C; Ramia P; Youssef B; Zeidan YH
Am J Clin Oncol; 2018 Dec; 41(12):1257-1262. PubMed ID: 29889137
[TBL] [Abstract][Full Text] [Related]
14. Topical use of recombinant human epidermal growth factor (EGF)-based cream to prevent radiation dermatitis in breast cancer patients: a single-blind randomized preliminary study.
Kong M; Hong SE
Asian Pac J Cancer Prev; 2013; 14(8):4859-64. PubMed ID: 24083759
[TBL] [Abstract][Full Text] [Related]
15. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
Pommier P; Gomez F; Sunyach MP; D'Hombres A; Carrie C; Montbarbon X
J Clin Oncol; 2004 Apr; 22(8):1447-53. PubMed ID: 15084618
[TBL] [Abstract][Full Text] [Related]
16. Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy.
Zhu W; Jia L; Chen G; Zhao H; Sun X; Meng X; Zhao X; Xing L; Yu J; Zheng M
Oncotarget; 2016 Jul; 7(30):48607-48613. PubMed ID: 27224910
[TBL] [Abstract][Full Text] [Related]
17. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
18. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
19. Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial.
Rahimi A; Mohamad O; Albuquerque K; Kim DWN; Chen D; Thomas K; Wooldridge R; Rivers A; Leitch M; Rao R; Haley B; Ahn C; Garwood D; Spangler A
Support Care Cancer; 2020 Mar; 28(3):1481-1489. PubMed ID: 31273506
[TBL] [Abstract][Full Text] [Related]
20. Breast intensity-modulated radiation therapy reduces time spent with acute dermatitis for women of all breast sizes during radiation.
Freedman GM; Li T; Nicolaou N; Chen Y; Ma CC; Anderson PR
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):689-94. PubMed ID: 19362779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]